Fukano, Reiji http://orcid.org/0000-0002-4087-3426
Mori, Tetsuya
Fujita, Naoto
Kobayashi, Ryoji
Mitsui, Tetsuo
Kato, Koji
Suzuki, Ritsuro
Suzumiya, Junji
Fukuda, Takahiro
Shindo, Motohiro
Maseki, Nobuo
Shimoyama, Tatsu
Okada, Keiko
Inoue, Masami
Inagaki, Jiro
Hashii, Yoshiko
Sato, Atsushi
Tabuchi, Ken
Article History
Received: 10 April 2019
Revised: 24 September 2019
Accepted: 25 September 2019
First Online: 16 October 2019
Compliance with ethical standards
:
: R. Suzuki reports personal fees from Bristol-Meyer Squib, Novartis Pharmaceuticals, Kyowa-Hakko Kirin, Chugai Pharmaceutical, Shionogi, Takeda Pharmaceutical, Meiji Seika Pharma, MSD, Otsuka Pharmaceutical, Sawai, Celgene, Sumitomo Dainippon Pharma, Eisai Pharmaceuticals, Alexion Pharma, Sano, Gilead Sciences, Abbvie Inc., Mundi Pharma, Jazz Pharma, Ono Pharmaceutical, and Janssen Pharmaceuticals, outside the submitted work. The other authors declare no relevant conflict of interest.